The MATISSE Titanium ACIF Cage with CTL Medical’s proprietary TiCro surface technology offers 200 percent greater endplate contact surface area, as well as bone conforming geometry for increased mechanical locking at the cage and bone interface. The implant includes a tapered leading edge for easy insertion and a large graft area to further promote bony fusion. The device is available in a variety of sizes and configurations to accommodate variations in vertebral levels and patient anatomy.
“Countless engineering hours and R&D resources went in to developing CTL Medical’s patent pending TiCro surface technology, which was designed to expand our current portfolio, advance fusion technologies, and offer spine surgeons numerous surgical advantages,” stated Danny Chon, president and CEO of CTL Medical Corporation. “The Matisse system includes streamlined instrumentation and a variety of footprints, heights and lordotic profiles to accommodate variations in patient anatomy.”
MATISSE Titanium ACIF Cage with TiCro is indicated for use in skeletally mature patients with degenerative disc disease (DDD) of the cervical spine with accompanying radicular symptoms at one-disc level. DDD is defined as discogenic pain with degeneration of the disc confirmed by patient history and radiographic studies.
MATISSE Anterior Cervical Interbody Fusion Cage system is used to facilitate intervertebral body fusion in the cervical spine at the C3 to C7 disc levels using autograft bone. MATISSE Titanium ACIF Cage with TiCro is to be used with supplemental fixation, such as CTL Medical’s VAN GOGH Anterior cervical plating system, which has been cleared for use in the cervical spine.
The use of cage devices in spinal surgery began with clinical trials in 1989, and since then, multiple implant improvements have debuted—leading to easier procedures, benefitting both spine surgeons and overall patient success and recovery times.
CTL Medical Corporation is a fully integrated, global medical device design, development and manufacturing company.